Rare Disease Genome Editing Market Report 2026
Download Free Sample Buy Now
Rare Disease Genome Editing Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Rare Disease Genome Editing Market Report 2026

Global Outlook – By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9, Transcription Activator-Like Effector Nucleases (TALEN), Zinc Finger Nucleases (ZFN), Other Technologies), By Disease Type (Monogenic Disorders, Multifactorial Disorders, Chromosomal Disorders), By Application (Therapeutics, Research), By End User (Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Hospitals) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Rare Disease Genome Editing Market Overview

• Rare Disease Genome Editing market size has reached to $1.29 billion in 2025

• Expected to grow to $2.88 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%

• Growth Driver: Increasing Focus On Precision Medicine Fueling The Growth Of The Market Due To Advances In Genomic Sequencing And Biomarker Identification

• Market Trend: CRISPR-Based Gene Editing Enhances Precision And Outcomes

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rare Disease Genome Editing Market?

Rare disease genome editing refers to the use of precise genetic modification technologies to correct or alter disease-causing mutations in patients with rare genetic disorders. It helps to restore normal gene function, prevent disease progression, and develop personalized therapeutic solutions for conditions that currently have limited or no treatment options. This approach aims to address the root cause of the disease at the DNA level rather than managing symptoms.

The main technologies used in rare disease genome editing are clustered regularly interspaced short palindromic repeats (CRISPR) or CRISPR-associated protein 9, transcription activator-like effector nucleases (TALEN), zinc finger nucleases (ZFN), and others. Clustered regularly interspaced short palindromic repeats (CRISPR) or CRISPR-associated protein 9 is a genome editing tool that uses a guide RNA and the Cas9 enzyme to precisely cut and modify DNA for research and therapeutic purposes. It is used for different disease types such as monogenic disorders, multifactorial disorders, and chromosomal disorders, and finds application in therapeutics and research, serving end users such as biotechnology and pharmaceutical companies, academic and government research institutes, and hospitals.

Rare Disease Genome Editing Market Global Report 2026 Market Report bar graph

What Is The Rare Disease Genome Editing Market Size and Share 2026?

The rare disease genome editing market size has grown rapidly in recent years. It will grow from $1.29 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to advancements in gene editing technologies, increasing identification of rare genetic mutations, expansion of genomic research funding, early success of gene therapy trials, growing academic research initiatives.

What Is The Rare Disease Genome Editing Market Growth Forecast?

The rare disease genome editing market size is expected to see rapid growth in the next few years. It will grow to $2.88 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing investment in curative rare disease therapies, rising adoption of precision medicine approaches, expansion of clinical genome editing trials, growing regulatory support for orphan drugs, increasing collaboration between biotech and healthcare providers. Major trends in the forecast period include increasing adoption of crispr-based therapeutics, rising focus on gene editing for monogenic disorders, growing use of personalized genome editing approaches, expansion of advanced editing platforms, enhanced integration of genomic data analytics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Rare Disease Genome Editing Market Segmentation

1) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9, Transcription Activator-Like Effector Nucleases (TALEN), Zinc Finger Nucleases (ZFN), Other Technologies

2) By Disease Type: Monogenic Disorders, Multifactorial Disorders, Chromosomal Disorders

3) By Application: Therapeutics, Research

4) By End User: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Hospitals

Subsegments:

1) By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Protein 9, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Protein 12, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Protein 13, Base Editing, Prime Editing

2) By Transcription Activator-Like Effector Nucleases (TALEN): Standard Transcription Activator-Like Effector Nucleases (TALEN), Designer Transcription Activator-Like Effector Nucleases (dTALEN), Transcription Activator-Like Effector Nucleases (TALEN) Paired Nucleases

3) By Zinc Finger Nucleases (ZFN): Standard Zinc Finger Nucleases (ZFN), Engineered Zinc Finger Nucleases (ZFN), Modular Zinc Finger Nucleases (ZFN)

4) By Other Technologies: Meganucleases, Ribonucleic Acid (RNA)-Guided Nucleases, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Transposases

What Is The Driver Of The Rare Disease Genome Editing Market?

The increasing focus on precision medicine is expected to propel the growth of the rare disease genome editing market going forward. Precision medicine refers to a tailored healthcare approach that uses a patient’s genetics, environment, and lifestyle to provide more accurate and effective treatments. The increasing focus on precision medicine is due to advances in genomic sequencing and biomarker identification, as they enable precise detection and targeted therapies. Rare disease genome editing market supports precision medicine by enabling targeted correction of genetic mutations, making treatments more personalized and effective. It advances healthcare by addressing the root cause of rare disorders, improving patient outcomes and reducing reliance on symptomatic management. For instance, in March 2024, Novotech, an Australia-based biotechnology company, in 2023, 43% of the 217 FDA-approved oncology therapies were precision oncology treatments, with 78 incorporating DNA or NGS-detectable biomarkers. Therefore, the increasing focus on precision medicine is driving the growth of the rare disease genome editing industry.

Key Players In The Global Rare Disease Genome Editing Market

Major companies operating in the rare disease genome editing market are Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Beam Therapeutics Inc., CRISPR Therapeutics AG, Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Editas Medicine Inc., Krystal Biotech Inc., Caribou Biosciences Inc, Bluebird Bio Inc., SpliceBio S.L., Cellectis SA, Generation Bio Co., iECURE Inc., Affinia Therapeutics Inc., Precision Biosciences Inc., Intellia Therapeutics Inc., MeiraGTx Holdings plc

Global Rare Disease Genome Editing Market Trends and Insights

Major companies operating in the rare disease genome editing market are focusing on developing advanced therapeutic platforms, such as CRISPR-based gene editing systems, to enhance treatment precision, improve therapeutic outcomes, and address previously incurable genetic diseases. CRISPR-based gene editing systems refer to innovative technologies that enable precise modifications to the genome, allowing for the correction of genetic defects or the introduction of therapeutic genes into cells. For instance, in December 2023, Vertex Pharmaceuticals Inc., a US-based biopharmaceutical company, partnered with CRISPR Therapeutics Inc., a US-based biotechnology research company, and received conditional marketing authorization from the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) for CASGEVY (exagamglogene autotemcel, exa-cel). It is indicated for patients aged 12 and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia (TDT). Casgevy works by editing a patient’s hematopoietic stem cells to reactivate fetal hemoglobin production, which reduces or eliminates disease symptoms and offers a potential functional cure for these conditions.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Rare Disease Genome Editing Market?

In May 2024, Arbor Biotechnologies Inc., a US-based biotechnology company, acquired Serendipity Biosciences for an undisclosed amount. With this acquisition, Arbor aimed to bolster its technological capabilities by integrating Serendipity’s novel gene-editing platforms, including Fanzor-based and IsrB-based systems, to expand its therapeutic reach, especially in reverse transcriptase–based editing and large DNA insertions. Serendipity Biosciences Inc. is a US-based biotechnology company specializing in the discovery and development of unique, programmable gene-editing technologies.

Regional Insights

North America was the largest region in the rare disease genome editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rare Disease Genome Editing Market?

The rare disease genome editing market consists of revenues earned by entities by providing services such as gene editing therapy development, genetic testing and diagnostics, preclinical research and validation, clinical trial management, and regulatory consulting for genome-based therapeutics. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare disease genome editing market also includes sales of zinc finger nucleases, delivery vectors, modified cells, and therapeutic genome-editing formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rare Disease Genome Editing Market Report 2026?

The rare disease genome editing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease genome editing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Rare Disease Genome Editing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.51 billion
Revenue Forecast In 2035 $2.88 billion
Growth Rate CAGR of 17.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Technology, Disease Type, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Beam Therapeutics Inc., CRISPR Therapeutics AG, Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Editas Medicine Inc.,
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Rare Disease Genome Editing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Rare Disease Genome Editing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Rare Disease Genome Editing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Rare Disease Genome Editing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of CRISPR-Based Therapeutics

4.2.2 Rising Focus On Gene Editing For Monogenic Disorders

4.2.3 Growing Use Of Personalized Genome Editing Approaches

4.2.4 Expansion Of Advanced Editing Platforms

4.2.5 Enhanced Integration Of Genomic Data Analytics

5. Rare Disease Genome Editing Market Analysis Of End Use Industries

5.1 Biotechnology Companies

5.2 Pharmaceutical Companies

5.3 Academic Research Institutes

5.4 Government Research Organizations

5.5 Hospitals

6. Rare Disease Genome Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rare Disease Genome Editing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Rare Disease Genome Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Rare Disease Genome Editing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Rare Disease Genome Editing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Rare Disease Genome Editing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rare Disease Genome Editing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rare Disease Genome Editing Market Segmentation

9.1. Global Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9, Transcription Activator-Like Effector Nucleases (TALEN), Zinc Finger Nucleases (ZFN), Other Technologies

9.2. Global Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monogenic Disorders, Multifactorial Disorders, Chromosomal Disorders

9.3. Global Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Therapeutics, Research

9.4. Global Rare Disease Genome Editing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Hospitals

9.5. Global Rare Disease Genome Editing Market, Sub-Segmentation Of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Protein 9, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Protein 12, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Protein 13, Base Editing, Prime Editing

9.6. Global Rare Disease Genome Editing Market, Sub-Segmentation Of Transcription Activator-Like Effector Nucleases (TALEN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Transcription Activator-Like Effector Nucleases (TALEN), Designer Transcription Activator-Like Effector Nucleases (dTALEN), Transcription Activator-Like Effector Nucleases (TALEN) Paired Nucleases

9.7. Global Rare Disease Genome Editing Market, Sub-Segmentation Of Zinc Finger Nucleases (ZFN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Zinc Finger Nucleases (ZFN), Engineered Zinc Finger Nucleases (ZFN), Modular Zinc Finger Nucleases (ZFN)

9.8. Global Rare Disease Genome Editing Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Meganucleases, Ribonucleic Acid (RNA)-Guided Nucleases, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Transposases

10. Rare Disease Genome Editing Market Regional And Country Analysis

10.1. Global Rare Disease Genome Editing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Rare Disease Genome Editing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rare Disease Genome Editing Market

11.1. Asia-Pacific Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rare Disease Genome Editing Market

12.1. China Rare Disease Genome Editing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rare Disease Genome Editing Market

13.1. India Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rare Disease Genome Editing Market

14.1. Japan Rare Disease Genome Editing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rare Disease Genome Editing Market

15.1. Australia Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rare Disease Genome Editing Market

16.1. Indonesia Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rare Disease Genome Editing Market

17.1. South Korea Rare Disease Genome Editing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rare Disease Genome Editing Market

18.1. Taiwan Rare Disease Genome Editing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rare Disease Genome Editing Market

19.1. South East Asia Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rare Disease Genome Editing Market

20.1. Western Europe Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rare Disease Genome Editing Market

21.1. UK Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rare Disease Genome Editing Market

22.1. Germany Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rare Disease Genome Editing Market

23.1. France Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rare Disease Genome Editing Market

24.1. Italy Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rare Disease Genome Editing Market

25.1. Spain Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rare Disease Genome Editing Market

26.1. Eastern Europe Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rare Disease Genome Editing Market

27.1. Russia Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rare Disease Genome Editing Market

28.1. North America Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rare Disease Genome Editing Market

29.1. USA Rare Disease Genome Editing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rare Disease Genome Editing Market

30.1. Canada Rare Disease Genome Editing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rare Disease Genome Editing Market

31.1. South America Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rare Disease Genome Editing Market

32.1. Brazil Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rare Disease Genome Editing Market

33.1. Middle East Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rare Disease Genome Editing Market

34.1. Africa Rare Disease Genome Editing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Rare Disease Genome Editing Market, Segmentation By Technology, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rare Disease Genome Editing Market Regulatory and Investment Landscape

36. Rare Disease Genome Editing Market Competitive Landscape And Company Profiles

36.1. Rare Disease Genome Editing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Rare Disease Genome Editing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Rare Disease Genome Editing Market Company Profiles

36.3.1. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Ultragenyx Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. CRISPR Therapeutics AG Overview, Products and Services, Strategy and Financial Analysis

37. Rare Disease Genome Editing Market Other Major And Innovative Companies

Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Editas Medicine Inc., Krystal Biotech Inc., Caribou Biosciences Inc, Bluebird Bio Inc., SpliceBio S.L., Cellectis SA, Generation Bio Co., iECURE Inc., Affinia Therapeutics Inc., Precision Biosciences Inc., Intellia Therapeutics Inc., MeiraGTx Holdings plc

38. Global Rare Disease Genome Editing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rare Disease Genome Editing Market

40. Rare Disease Genome Editing Market High Potential Countries, Segments and Strategies

40.1 Rare Disease Genome Editing Market In 2030 - Countries Offering Most New Opportunities

40.2 Rare Disease Genome Editing Market In 2030 - Segments Offering Most New Opportunities

40.3 Rare Disease Genome Editing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Rare Disease Genome Editing Market, Overview Of Key Products - Product Examples
  • Table 2: Global Rare Disease Genome Editing Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Rare Disease Genome Editing Market, Supply Chain Analysis
  • Table 4: Global Rare Disease Genome Editing Market, Major Raw Material Providers
  • Table 5: Global Rare Disease Genome Editing Market, Major Resource Providers
  • Table 6: Global Rare Disease Genome Editing Market, Major Manufacturers (Suppliers)
  • Table 7: Global Rare Disease Genome Editing Market, Major Distributors And Channel Partners
  • Table 8: Global Rare Disease Genome Editing Market, Key Technologies & Future Trends
  • Table 9: Global Rare Disease Genome Editing Market, Major Trends
  • Table 10: Global Rare Disease Genome Editing Market, Major End Users
  • Table 11: Global Rare Disease Genome Editing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Rare Disease Genome Editing Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Rare Disease Genome Editing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Rare Disease Genome Editing Market - TAM, US$ Billion, 2025
  • Table 15: Global Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Rare Disease Genome Editing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Transcription Activator-Like Effector Nucleases (TALEN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Zinc Finger Nucleases (ZFN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Rare Disease Genome Editing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Rare Disease Genome Editing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Rare Disease Genome Editing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Rare Disease Genome Editing Market - Company Scoring Matrix
  • Table 99: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 100: Sarepta Therapeutics Inc. Financial Performance
  • Table 101: Ultragenyx Pharmaceutical Inc. Financial Performance
  • Table 102: Beam Therapeutics Inc. Financial Performance
  • Table 103: CRISPR Therapeutics AG Financial Performance
  • Table 104: Global Rare Disease Genome Editing Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Rare Disease Genome Editing Market, Competitive Dashboard
  • Table 106: Global Rare Disease Genome Editing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Rare Disease Genome Editing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 108: Global, Rare Disease Genome Editing Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 109: Global, Rare Disease Genome Editing Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Rare Disease Genome Editing Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Rare Disease Genome Editing Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Rare Disease Genome Editing Market, Supply Chain Analysis
  • Figure 4: Global Rare Disease Genome Editing Market, Major Raw Material Providers
  • Figure 5: Global Rare Disease Genome Editing Market, Major Resource Providers
  • Figure 6: Global Rare Disease Genome Editing Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Rare Disease Genome Editing Market, Major Distributors And Channel Partners
  • Figure 8: Global Rare Disease Genome Editing Market, Key Technologies & Future Trends
  • Figure 9: Global Rare Disease Genome Editing Market, Major Trends
  • Figure 10: Global Rare Disease Genome Editing Market, Major End Users
  • Figure 11: Global Rare Disease Genome Editing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Rare Disease Genome Editing Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Rare Disease Genome Editing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Rare Disease Genome Editing Market - TAM, US$ Billion, 2025
  • Figure 15: Global Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Rare Disease Genome Editing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or CRISPR-Associated Protein 9, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Transcription Activator-Like Effector Nucleases (TALEN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Zinc Finger Nucleases (ZFN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Rare Disease Genome Editing Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Rare Disease Genome Editing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Rare Disease Genome Editing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Rare Disease Genome Editing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Rare Disease Genome Editing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Rare Disease Genome Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Rare Disease Genome Editing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Rare Disease Genome Editing Market - Company Scoring Matrix
  • Figure 99: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 100: Sarepta Therapeutics Inc. Financial Performance
  • Figure 101: Ultragenyx Pharmaceutical Inc. Financial Performance
  • Figure 102: Beam Therapeutics Inc. Financial Performance
  • Figure 103: CRISPR Therapeutics AG Financial Performance
  • Figure 104: Global Rare Disease Genome Editing Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Rare Disease Genome Editing Market, Competitive Dashboard
  • Figure 106: Global Rare Disease Genome Editing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Rare Disease Genome Editing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 108: Global, Rare Disease Genome Editing Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 109: Global, Rare Disease Genome Editing Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Genome Editing/Genome Engineering Market Report 2026 - Global Outlook – By Product And Service (Reagents And Consumables, Software And Systems, Services ), By Technology (CRISPR, TALEN, ZFN, Antisense, Other Technologies...

CRISPR Gene Editing Market Report 2026 - Global Outlook – By Type (CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types), By S...

Gene Editing Market Report 2026 - Global Outlook – By Technology (CRISPR, TALEN, ZFN ), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmace...

Rare Diseases Treatment Market Report 2026 - Global Outlook – By Drug Type (Originator Drugs (Patented Molecules), Generic Drugs), By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectable, Oral...

Rare Disease Diagnostics Market Report 2026 - Global Outlook – By Test Type (Genetic Test, General Lab Test, Imaging Test), By Technology (Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarray...

Digital Genome Market Report 2026 - Global Outlook – By Type (Sequencing And Analyzer Instruments, Data Analysis And Management Tools), By Application (Diagnostics, Agriculture And Animal Research, Personalized Medicine,...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Frequently Asked Questions

The Rare Disease Genome Editing market was valued at $1.29 billion in 2025, increased to $1.51 billion in 2026, and is projected to reach $2.88 billion by 2030.

The global Rare Disease Genome Editing market is expected to grow at a CAGR of 17.5% from 2026 to 2035 to reach $2.88 billion by 2035.

Some Key Players in the Rare Disease Genome Editing market Include, Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Beam Therapeutics Inc., CRISPR Therapeutics AG, Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Editas Medicine Inc., Krystal Biotech Inc., Caribou Biosciences Inc, Bluebird Bio Inc., SpliceBio S.L., Cellectis SA, Generation Bio Co., iECURE Inc., Affinia Therapeutics Inc., Precision Biosciences Inc., Intellia Therapeutics Inc., MeiraGTx Holdings plc .

Major trend in this market includes: CRISPR-Based Gene Editing Enhances Precision And Outcomes. For further insights on this market. request a sample here

North America was the largest region in the rare disease genome editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease genome editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us